The proposed renewal of the Johns Hopkins University (JHU) Center will continue to be led by Director Dr. Jusfin C McArthur. To manage the Center, centralize administrative functions, and most efficiently support the Center-affiliated faculty at JHU, we propose to have the same leadership for the Administrative Core (AC) as for the overall Center's Executive Committee. The AC will be supported by the Center's Administrative Assistant. The AC will serve as the administrative base of the Center and will continue to be housed within the University's Department of Neurology, located on the Johns Hopkins Medical Institutions (JHMI) campus which will enable efficient management across the three affiliated Schools of Medicine (SOM), Bloomberg School of Public Health (BSPH), and School of Nursing (SON). The rafionale for a centralized AC is to have stream lined management and administration in order to maximize efficiency of personnel, resources and ease of use for CFAR researchers, provide overall scientific and programmafic leadership, fiscal oversight and support, and to integrate communicafions and informafion resources to maximize CFAR utility, value, and cohesiveness in support of HIV research at Johns Hopkins. Administrative and financial management, as well as compliance oversight, will be managed through the Office of the Vice Dean for Research in the School of Medicine. The overarching theme of the Center is the development of novel therapeutics targeting sustained CNS inflammation for HIV-associated neurocognitive disorders (HAND). We have identified this as a high priority on the basis of our institutional strengths, our studies of neuropathogenesis both in humans and SIV encephalitis models, and the confinuing importance in clinical care of these disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Center Core Grants (P30)
Project #
3P30MH075673-07S1
Application #
8525435
Study Section
Special Emphasis Panel (ZMH1-ERB-F)
Project Start
Project End
2013-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
7
Fiscal Year
2012
Total Cost
$17,989
Indirect Cost
$6,885
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Rojas, Camilo; Stathis, Marigo; Coughlin, Jennifer M et al. (2018) The Low-Affinity Binding of Second Generation Radiotracers Targeting TSPO is Associated with a Unique Allosteric Binding Site. J Neuroimmune Pharmacol 13:1-5
Chan, Parco; Saleem, Mahwesh; Herrmann, Nathan et al. (2018) Ceramide Accumulation Is Associated with Declining Verbal Memory in Coronary Artery Disease Patients: An Observational Study. J Alzheimers Dis 64:1235-1246
Mohamed, M; Barker, P B; Skolasky, R L et al. (2018) 7T Brain MRS in HIV Infection: Correlation with Cognitive Impairment and Performance on Neuropsychological Tests. AJNR Am J Neuroradiol 39:704-712
Sacktor, Ned; Skolasky, Richard L; Moxley, Richard et al. (2018) Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trial. J Neurovirol 24:16-27
Barinka, Cyril; Novakova, Zora; Hin, Niyada et al. (2018) Structural and computational basis for potent inhibition of glutamate carboxypeptidase II by carbamate-based inhibitors. Bioorg Med Chem :
Lemberg, Kathryn M; Vornov, James J; Rais, Rana et al. (2018) We're Not ""DON"" Yet: Optimal Dosing and Prodrug Delivery of 6-Diazo-5-oxo-L-norleucine. Mol Cancer Ther 17:1824-1832
Capó-Vélez, Coral M; Delgado-Vélez, Manuel; Báez-Pagán, Carlos A et al. (2018) Nicotinic Acetylcholine Receptors in HIV: Possible Roles During HAND and Inflammation. Cell Mol Neurobiol :
Nedelcovych, Michael T; Gadiano, Alexandra J; Wu, Ying et al. (2018) Pharmacokinetics of Intranasal versus Subcutaneous Insulin in the Mouse. ACS Chem Neurosci 9:809-816
Sacktor, Ned (2018) Changing clinical phenotypes of HIV-associated neurocognitive disorders. J Neurovirol 24:141-145
Capó-Vélez, Coral M; Morales-Vargas, Bryan; García-González, Aurian et al. (2018) The alpha7-nicotinic receptor contributes to gp120-induced neurotoxicity: implications in HIV-associated neurocognitive disorders. Sci Rep 8:1829

Showing the most recent 10 out of 164 publications